Kantoff PW - Search Results

1

Mutations in ribonuclease L gene do not occur at a greater frequency in patients with familial prostate cancer compared with patients with sporadic prostate cancer.

Downing SR, Hennessy KT, Abe M, Manola J, George DJ, Kantoff PW. Downing SR, et al. Among authors: kantoff pw. Clin Prostate Cancer. 2003 Dec;2(3):177-80. doi: 10.3816/cgc.2003.n.027. Clin Prostate Cancer. 2003. PMID: 15040862

2

Two differentially expressed genes in normal human prostate tissue and in carcinoma.

Wang FL, Wang Y, Wong WK, Liu Y, Addivinola FJ, Liang P, Chen LB, Kantoff PW, Pardee AB. Wang FL, et al. Among authors: kantoff pw. Cancer Res. 1996 Aug 15;56(16):3634-7. Cancer Res. 1996. PMID: 8705997

3

Regulation of S100P expression by androgen.

Averboukh L, Liang P, Kantoff PW, Pardee AB. Averboukh L, et al. Among authors: kantoff pw. Prostate. 1996 Dec;29(6):350-5. doi: 10.1002/(SICI)1097-0045(199612)29:6<350::AID-PROS2>3.0.CO;2-C. Prostate. 1996. PMID: 8977631

4

A polymorphism of the 5 alpha-reductase gene and its association with prostate cancer: a case-control analysis.

Kantoff PW, Febbo PG, Giovannucci E, Krithivas K, Dahl DM, Chang G, Hennekens CH, Brown M, Stampfer MJ. Kantoff PW, et al. Cancer Epidemiol Biomarkers Prev. 1997 Mar;6(3):189-92. Cancer Epidemiol Biomarkers Prev. 1997. PMID: 9138662

5

Debrisoquine hydroxylase (CYP2D6) and prostate cancer.

Febbo PG, Kantoff PW, Giovannucci E, Brown M, Chang G, Hennekens CH, Stampfer M. Febbo PG, et al. Among authors: kantoff pw. Cancer Epidemiol Biomarkers Prev. 1998 Dec;7(12):1075-8. Cancer Epidemiol Biomarkers Prev. 1998. PMID: 9865424

6

Prognostic indicators in hormone refractory prostate cancer.

George DJ, Kantoff PW. George DJ, et al. Among authors: kantoff pw. Urol Clin North Am. 1999 May;26(2):303-10, viii. doi: 10.1016/s0094-0143(05)70070-7. Urol Clin North Am. 1999. PMID: 10361553 Review.

7

A phase II trial of methotrexate, cisplatin, 5-fluorouracil, and leucovorin in the treatment of invasive and metastatic urothelial carcinoma.

Oh WK, Manola J, Richie JP, Loughlin KR, Kantoff PW. Oh WK, et al. Among authors: kantoff pw. Cancer. 1999 Oct 1;86(7):1329-34. doi: 10.1002/(sici)1097-0142(19991001)86:7<1329::aid-cncr31>3.0.co;2-r. Cancer. 1999. PMID: 10506721 Clinical Trial.

8

The V89L polymorphism in the 5alpha-reductase type 2 gene and risk of prostate cancer.

Febbo PG, Kantoff PW, Platz EA, Casey D, Batter S, Giovannucci E, Hennekens CH, Stampfer MJ. Febbo PG, et al. Among authors: kantoff pw. Cancer Res. 1999 Dec 1;59(23):5878-81. Cancer Res. 1999. PMID: 10606227 Clinical Trial.

9

Smoking and alcohol use may be risk factors for poorer outcome in patients with clear cell renal carcinoma.

Oh WK, Manola J, Renshaw AA, Brodkin D, Loughlin KR, Richie JP, Shapiro CL, Kantoff PW. Oh WK, et al. Among authors: kantoff pw. Urology. 2000 Jan;55(1):31-5. doi: 10.1016/s0090-4295(99)00408-2. Urology. 2000. PMID: 10654890

10

Vinorelbine and estramustine in androgen-independent metastatic prostate cancer: a phase II study.

Smith MR, Kaufman D, Oh W, Guerin K, Seiden M, Makatsoris T, Manola J, Kantoff PW. Smith MR, et al. Among authors: kantoff pw. Cancer. 2000 Oct 15;89(8):1824-8. doi: 10.1002/1097-0142(20001015)89:8<1824::aid-cncr24>3.0.co;2-r. Cancer. 2000. PMID: 11042579 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

482 results

Search Page

Filters